BBWI – 2025-12-02 - decrease Confidence 8/10

BBWI – decrease in Days/Weeks

Free cash flow is positive at $660 million, but negative net income and deteriorating equity (-$1.548 billion) reveal structural profitability issues. Recent Q3 earnings miss and steep guidance cut to $2.87 EPS from consensus $3.41 triggered a wave of analyst downgrades and price target reductions.

Why This Matters

The combination of declining sales, eroding investor confidence, and liquidity concerns—highlighted by a troubling 0.4 quick ratio—signals that Bath & Body Works is facing fundamental headwinds just after the critical holiday shopping period. With multiple Wall Street firms cutting targets and the stock already down sharply post-earnings, the near-term price action is dominated by sentiment deterioration and technical weakness, leaving little room for upside surprise in the coming weeks.

Key Insights

• Q3 EPS & Sales Decline: EPS fell to $0.35 from $0.49 YoY, with sales dropping to $1.59B from $1.61B, missing estimates.
• News Impact: Goldman Sachs, Baird, and JPMorgan downgraded or cut price targets, citing weak guidance and margin pressure.
• Risk/Offset: Despite a new $250M cost-saving plan, negative book value and poor Disney collaboration performance undermine turnaround credibility.

Practical Implications

• Bull Case: Short-term bounce possible on oversold conditions or buy-the-dip sentiment, targeting $20–$21 resistance.
• Bear Case: Technical breakdown supports further downside toward $13.50, especially if macro or retail sentiment sours.
• Confidence: 8/10 – Earnings disappointment, downgrades, and balance sheet risks align for continued near-term weakness.

Prediction: decrease

Reference:

• https://www.timothysykes.com/news/bathbodyworksinc-bbwi-news-2025_11_21/